VEGFA and macular retinal edema: This review aims to analyze the available scientific literature regarding the clinical and imaging criteria for switching from intravitreal anti-VEGF therapy to an intravitreal DEX implant in patients affected by macular edema secondary to RVO, also focusing on OCT parameters that may guide this therapeutical choice or identify naive patients in whom corticosteroid therapy could represent the first-line therapy.